Havencrest Healthcare Partners, L.P.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
60
Insider Sells Sum
$10.87M

Insider Activity of Havencrest Healthcare Partners, L.P.

According to the SEC Form 4 filings, Havencrest Healthcare Partners, L.P., being in a position of

  1. 10 percent owner at The Oncology Institute, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 80000 shares for $173,697,
    over all time since 2022-08-12, has bought 0 shares, and sold 2432178 shares for $10.87M.

The largest sale of all time was on 2022-09-16 and amounted to 200000 shares of The Oncology Institute, Inc. for $900,000.

Biography of Havencrest Healthcare Partners, L.P.

No biography is available at this moment.

2024-01-29SaleThe Oncology Institute, Inc.
TOI
10 percent owner
8,637
0.0114%
$2.12$18,310-68.55%
2024-01-26SaleThe Oncology Institute, Inc.
TOI
10 percent owner
6,979
0.0096%
$2.14$14,935-63.09%
2024-01-25SaleThe Oncology Institute, Inc.
TOI
10 percent owner
11,882
0.0161%
$2.07$24,596-58.01%
2024-01-24SaleThe Oncology Institute, Inc.
TOI
10 percent owner
24,915
0.0356%
$2.30$57,305-59.79%
2024-01-23SaleThe Oncology Institute, Inc.
TOI
10 percent owner
5,338
0.0071%
$2.11$11,263-58.52%
2024-01-22SaleThe Oncology Institute, Inc.
TOI
10 percent owner
10,263
0.0139%
$2.12$21,758-57.75%
2024-01-19SaleThe Oncology Institute, Inc.
TOI
10 percent owner
11,986
0.0161%
$2.13$25,530-58.33%
2022-11-11SaleThe Oncology Institute, Inc.
TOI
director
365,321
0.5392%
$2.33$851,198-53.46%
2022-11-10SaleThe Oncology Institute, Inc.
TOI
director
61,281
0.0854%
$2.98$182,617-64.97%
2022-11-09SaleThe Oncology Institute, Inc.
TOI
director
80,000
0.1096%
$3.09$247,200-66.77%
2022-11-08SaleThe Oncology Institute, Inc.
TOI
director
27,000
0.0371%
$3.24$87,480-68.21%
2022-11-07SaleThe Oncology Institute, Inc.
TOI
director
19,167
0.0263%
$3.28$62,868-68.6%
2022-11-04SaleThe Oncology Institute, Inc.
TOI
director
50,200
0.0686%
$3.39$170,178-70.38%
2022-11-03SaleThe Oncology Institute, Inc.
TOI
director
45,500
0.0629%
$3.58$162,890-71.07%
2022-11-02SaleThe Oncology Institute, Inc.
TOI
director
58,500
0.0825%
$3.94$230,490-73.18%
2022-11-01SaleThe Oncology Institute, Inc.
TOI
director
50,272
0.0709%
$4.26$214,159-75.18%
2022-10-31SaleThe Oncology Institute, Inc.
TOI
director
41,855
0.0594%
$4.69$196,300-77.31%
2022-10-28SaleThe Oncology Institute, Inc.
TOI
director
52,091
0.0717%
$4.84$252,120-79.09%
2022-10-27SaleThe Oncology Institute, Inc.
TOI
director
35,000
0.0484%
$5.09$178,150-79.64%
2022-10-26SaleThe Oncology Institute, Inc.
TOI
director
52,500
0.0713%
$5.16$270,900-80.27%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.